Night work and prostate cancer risk: results from the EPICAP Study
Wendeu-Foyet, Méyomo Gaelle ; Bayon, Virginie ; Cénée, Sylvie ; Trétarre, Brigitte ; Rébillard, Xavier ; Cancel-Tassin, Géraldine ; Cussenot, Olivier ; Lamy, Pierre-Jean ; Faraut, Brice ; Ben Khedher, Soumaya ; Menegaux, Florence
Occupational and Environmental Medicine
2018
75
8
573-581
occupational disease ; prostate cancer ; occupational risks ; night work ; case control study
Occupational diseases
http://dx.doi.org/10.1136/oemed-2018-105009
English
Bibliogr.
"Objective
To investigate the role of night work in prostate cancer based on data from the EPICAP Study.
Methods
EPICAP is a French population-based case-control study including 818 incident prostate cancer cases and 875 frequency-matched controls that have been interviewed face to face on several potential risk factors including lifetime occupational history. Detailed information on work schedules for each job (permanent or rotating night work, duration, total number of nights, length of the shift, number of consecutive nights) as well as sleep duration and chronotype, was gathered. Prostate cancer aggressiveness was assessed by Gleason Score.
Results
Night work was not associated with prostate cancer, whatever the aggressiveness of prostate cancer, while we observed an overall increased risk among men with an evening chronotype (OR=1.83, 95% CI 1.05 to 3.19). A long duration of at least 20 years of permanent night work was associated with aggressive prostate cancer (OR=1.76, 95% CI 1.13 to 2.75), even more pronounced in combination with a shift length >10 hours or ≥ 6 consecutive nights (OR=4.64, 95% CI 1.78 to 12.13; OR=2.43, 95% CI 1.32 to 4.47, respectively).
Conclusion
Overall, ever night work, either permanent or rotating, was not associated to prostate cancer. Nevertheless, our results suggest that a long duration of permanent night work in combination with a long shift length or at least six consecutive nights may be associated with prostate cancer, particularly with aggressive prostate cancer. Further studies are needed to confirm those findings."
Digital
The ETUI is co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the ETUI.